- Round ID
- FR-00024
- Stage
- Series C (second close)
- Round name
- Series C (second close)
- Amount
- $33.5M
Dated funding evidence
Apollo Therapeutics
Series C (second close) · $33.5M · 2024-01-02
Reported round$33.5MSeries C (second close)
- Disclosure date
- 2024-01-02
- Reported currency
- USD
- Companies House
- 13393274
- Evidence sources
- 1
2024-01-02Series C (second close)$33.5M
Resolved investor records
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- Not stated
- Other investors
- M&G plc, Rock Springs Capital, two large US public pension plans
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-15
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.